BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 16887931)

  • 1. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.
    Qian WJ; Jacobs JM; Liu T; Camp DG; Smith RD
    Mol Cell Proteomics; 2006 Oct; 5(10):1727-44. PubMed ID: 16887931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of LC/MS to proteomics studies: current status and future prospects.
    Chen G; Pramanik BN
    Drug Discov Today; 2009 May; 14(9-10):465-71. PubMed ID: 19429505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry-based plasma proteomics: state of the art and future outlook.
    Pernemalm M; Lehtiƶ J
    Expert Rev Proteomics; 2014 Aug; 11(4):431-48. PubMed ID: 24661227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTICR mass spectrometry for qualitative and quantitative bioanalyses.
    Page JS; Masselon CD; Smith RD
    Curr Opin Biotechnol; 2004 Feb; 15(1):3-11. PubMed ID: 15102459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics technologies for the global identification and quantification of proteins.
    Brewis IA; Brennan P
    Adv Protein Chem Struct Biol; 2010; 80():1-44. PubMed ID: 21109216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of strong cation exchange versus isoelectric focusing of peptides for multidimensional liquid chromatography-tandem mass spectrometry.
    Slebos RJ; Brock JW; Winters NF; Stuart SR; Martinez MA; Li M; Chambers MC; Zimmerman LJ; Ham AJ; Tabb DL; Liebler DC
    J Proteome Res; 2008 Dec; 7(12):5286-94. PubMed ID: 18939861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proteomic future: where mass spectrometry should be taking us.
    Thelen JJ; Miernyk JA
    Biochem J; 2012 Jun; 444(2):169-81. PubMed ID: 22574775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale multiplexed quantitative discovery proteomics enabled by the use of an (18)O-labeled "universal" reference sample.
    Qian WJ; Liu T; Petyuk VA; Gritsenko MA; Petritis BO; Polpitiya AD; Kaushal A; Xiao W; Finnerty CC; Jeschke MG; Jaitly N; Monroe ME; Moore RJ; Moldawer LL; Davis RW; Tompkins RG; Herndon DN; Camp DG; Smith RD;
    J Proteome Res; 2009 Jan; 8(1):290-9. PubMed ID: 19053531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in mass spectrometry instrumentation for proteomics.
    Smith RD
    Trends Biotechnol; 2002 Dec; 20(12 Suppl):S3-7. PubMed ID: 12570152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances on multidimensional liquid chromatography-mass spectrometry for proteomics: from qualitative to quantitative analysis--a review.
    Wu Q; Yuan H; Zhang L; Zhang Y
    Anal Chim Acta; 2012 Jun; 731():1-10. PubMed ID: 22652259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.
    Manes NP; Nita-Lazar A
    J Proteomics; 2018 Oct; 189():75-90. PubMed ID: 29452276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient Quantitative Comparisons of Plasma Proteomes Using Label-Free Analysis with MaxQuant.
    Beer LA; Liu P; Ky B; Barnhart KT; Speicher DW
    Methods Mol Biol; 2017; 1619():339-352. PubMed ID: 28674895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.
    Liu T; Qian WJ; Gritsenko MA; Camp DG; Monroe ME; Moore RJ; Smith RD
    J Proteome Res; 2005; 4(6):2070-80. PubMed ID: 16335952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of Three-Dimensional Liquid Chromatography Platforms for Bottom-Up Proteomics.
    Duong VA; Park JM; Lee H
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
    Lee HJ; Lee EY; Kwon MS; Paik YK
    Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry-based proteomics: basic principles and emerging technologies and directions.
    Van Riper SK; de Jong EP; Carlis JV; Griffin TJ
    Adv Exp Med Biol; 2013; 990():1-35. PubMed ID: 23378000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
    Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
    J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in capillary separations for proteomics.
    Cooper JW; Wang Y; Lee CS
    Electrophoresis; 2004 Dec; 25(23-24):3913-26. PubMed ID: 15597423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine sample preparation and fractionation for global proteome profiling by LC-MS.
    Court M; Garin J; Masselon CD
    Methods Mol Biol; 2015; 1243():175-86. PubMed ID: 25384746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.